UBS analysts reduced their price target on Jazz Pharmaceuticals (NASDAQ:JAZZ) to $113 from $117, while maintaining a Neutral rating on the stock. The analysts p

UBS Lowers Price Target on Jazz Pharmaceuticals

- (Last modified: Jul 3, 2024 2:55 AM)

blog post cover photo

Image credit: FMP

UBS analysts reduced their price target on Jazz Pharmaceuticals (NASDAQ:JAZZ) to $113 from $117, while maintaining a Neutral rating on the stock. The analysts pointed out that the stock's performance is heavily dependent on capital allocation and its performance in 2024, both of which they view as potentially disappointing.

Regarding capital allocation, the analysts suggested that while Jazz aims to achieve its Vision 2025 through mergers and acquisitions, a significant share repurchase could be a more favorable strategy for boosting the stock. They noted that share buybacks are at a high in the broader market and have been positively received by investors in other biopharma companies that have executed significant buybacks.

For fiscal year 2024, the analysts expressed concerns about Jazz's ability to meet its guidance midpoint, particularly due to ongoing pressure on its Sleep franchise. Their estimates for Q2/24 earnings and the full year are at the lower end of Jazz's guidance and below Street expectations.

Other Blogs

Nov 25, 2023 6:39 AM - Parth Sanghvi

DCF Valuation vs. Comparable Companies Analysis: Choosing the Right Valuation Method

Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...

blog post title

Dec 23, 2023 2:19 AM - Parth Sanghvi

Understanding the Limitations of DCF Analysis: A Guide to Overcoming Challenges

Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...

blog post title

Dec 25, 2023 2:28 AM - Parth Sanghvi

Integrating Sustainability into Valuations: Navigating ESG Factors within the Discounted Cash Flow (DCF) Model

Introduction: The investment landscape is undergoing a profound shift with a heightened emphasis on sustainability and responsible investing. In this blog post, we explore the intersection of Environmental, Social, and Governance (ESG) considerations within the Discounted Cash Flow (DCF) model, h...

blog post title


Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
2017-2024 © Financial Modeling Prep